Clinical Trial Update: MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating MLC1501 for motor deficits after stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptogenic Stroke
• Embolic Stroke
• Stroke

Drugs mentioned

• MLC1501

Snippet

Sponsor: Moleac Pte Ltd. | Conditions: Stroke, Stroke, Ischemic | Phase 2 | Status: COMPLETED